Literature DB >> 8055996

Adenosine for the management of patients with tachycardias--a new protocol.

H Domanovits1, H Laske, G Stark, F Sterz, H Schmidinger, W Schreiber, M Müllner, A N Laggner.   

Abstract

We developed a new protocol for diagnosis and treatment of patients with sustained tachycardias (heart rate > 150 beats.min-1). The patients first underwent vagal manoeuvres; if those remained unsuccessful, i.v. adenosine in increasing doses of 6, 12, and 18 mg was administered until sinus rhythm (SR) or transient atrioventricular (AV) block, unmasking the underlying rhythm, was recorded. In the latter and in the non-responding cases other antiarrhythmics were applied. Ninety-three episodes of tachycardia in 46 patients were treated according to this protocol. Six episodes (6%) were terminated by carotid massage, 64 of the remaining 87 episodes (74%) responded to adenosine with return to SR. Conversion to SR occurred more often in episodes with narrow- than in wide-complex tachycardia (81 vs. 59%, P < 0.05). To achieve SR, the mean adenosine dose was lower in narrow- than in wide-complex tachycardia (13 +/- 8 vs 21 +/- 10 mg; P < 0.01). The duration of asystole after adenosine did not differ between these two groups, whereas the duration of arrhythmia after adenosine differed significantly (8.5 +/- 5.8 vs 18.6 +/- 22.9 s; P < 0.05). Side effects of adenosine such as flush, dyspnoea, and chest pain did not seem to be dose dependent and occurred in about 20%. According to our protocol, in more than 75% SR was achieved in patients with sustained tachycardias after vagal manoeuvres and adenosine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055996     DOI: 10.1093/oxfordjournals.eurheartj.a060553

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  Prehospital use of adenosine by ambulance services in the Netherlands: Daily practice, literature overview and practical recommendations.

Authors:  R Adams; V Bon
Journal:  Neth Heart J       Date:  2003-05       Impact factor: 2.380

Review 3.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

4.  Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients.

Authors:  Sandra Beijer; Eric A R Gielisse; Pierre S Hupperets; Ben E E M van den Borne; Marieke van den Beuken-van Everdingen; Marten R Nijziel; Arjen M J van Henten; Pieter C Dagnelie
Journal:  Invest New Drugs       Date:  2007-09-05       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.